157 related articles for article (PubMed ID: 1419827)
1. Regulation of iron absorption in iron loaded subjects with end stage renal disease: effects of treatment with recombinant human erythropoietin and reduction of iron stores.
Hughes RT; Smith T; Hesp R; Hulme B; Dukes DC; Bending MB; Pearson J; Raja KB; Cotes PM; Pippard MJ
Br J Haematol; 1992 Oct; 82(2):445-54. PubMed ID: 1419827
[TBL] [Abstract][Full Text] [Related]
2. Variations in erythropoiesis and serum ferritin during erythropoietin therapy for anaemia of end-stage renal disease.
Barosi G; Merlo C; Palestra P; Liberato NL; Guarnone R; Di Dio F; Piazza V; Salvadeo A
Acta Haematol; 1993; 90(1):13-8. PubMed ID: 8237268
[TBL] [Abstract][Full Text] [Related]
3. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
[TBL] [Abstract][Full Text] [Related]
4. Effects of erythropoietin therapy on iron absorption in chronic renal failure.
Skikne BS; Ahluwalia N; Fergusson B; Chonko A; Cook JD
J Lab Clin Med; 2000 Jun; 135(6):452-8. PubMed ID: 10850644
[TBL] [Abstract][Full Text] [Related]
5. Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium.
Kooistra MP; Niemantsverdriet EC; van Es A; Mol-Beermann NM; Struyvenberg A; Marx JJ
Nephrol Dial Transplant; 1998 Jan; 13(1):82-8. PubMed ID: 9481720
[TBL] [Abstract][Full Text] [Related]
6. Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease.
Stevens ME; Summerfield GP; Hall AA; Beck CA; Harding AJ; Cove-Smith JR; Paterson AD
BMJ; 1992 Feb; 304(6825):474-7. PubMed ID: 1547417
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of intravenous administration of Fe-gluconate-Na complex to maintain adequate body iron stores in hemodialysis patients.
Navarro JF; Teruel JL; Liaño F; Marcén R; Ortuño J
Am J Nephrol; 1996; 16(4):268-72. PubMed ID: 8739277
[TBL] [Abstract][Full Text] [Related]
8. Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietin.
Kooistra MP; van Es A; Struyvenberg A; Marx JJ
Br J Haematol; 1991 Dec; 79(4):634-9. PubMed ID: 1772785
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin treatment in haemodialysis patients with iron overload.
el-Reshaid K; Johny KV; Hakim A; Kamel H; Sebeta A; Hourani H; Kanyike FB
Acta Haematol; 1994; 91(3):130-5. PubMed ID: 8091934
[TBL] [Abstract][Full Text] [Related]
10. Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin.
Howarth JE; Waters HM; Shanks D; Hyde K; Yin JA; Geary CG; Anastassiades E; Howarth D; Gokal R
J Clin Pathol; 1993 Jan; 46(1):41-4. PubMed ID: 8432886
[TBL] [Abstract][Full Text] [Related]
11. Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy.
McCarthy JT; Johnson WJ; Nixon DE; Jenson BM; Moyer TP
J Lab Clin Med; 1989 Aug; 114(2):193-9. PubMed ID: 2754306
[TBL] [Abstract][Full Text] [Related]
12. The use of recombinant human erythropoietin in end stage renal disease.
Conlon PJ; Walshe JJ; O'Donnell R; O'Donohoe A; Spencer R; Donohoe J; Carmody M
Ir J Med Sci; 1993 Jan; 162(1):17-9. PubMed ID: 8440603
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin therapy in children maintained by haemodialysis.
Rigden SP; Montini G; Morris M; Clark KG; Haycock GB; Chantler C; Hill RC
Pediatr Nephrol; 1990 Nov; 4(6):618-22. PubMed ID: 2088464
[TBL] [Abstract][Full Text] [Related]
14. [Iron stores in patients with chronic kidney failure treated with recombinant human erythropoietin].
Cermák J; Gregora E; Lachmanová J; Brabec V
Vnitr Lek; 1994 Mar; 40(3):174-8. PubMed ID: 8184571
[TBL] [Abstract][Full Text] [Related]
15. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
[TBL] [Abstract][Full Text] [Related]
16. Effect of enhanced erythropoiesis on iron absorption.
Skikne BS; Cook JD
J Lab Clin Med; 1992 Nov; 120(5):746-51. PubMed ID: 1431504
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients.
Lazarus JM; Hakim RM; Newell J
Am J Kidney Dis; 1990 Aug; 16(2):101-8. PubMed ID: 2382644
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure.
Tomson CR; Edmunds ME; Chambers K; Bricknell S; Feehally J; Walls J
Nephrol Dial Transplant; 1992; 7(8):817-21. PubMed ID: 1325614
[TBL] [Abstract][Full Text] [Related]
19. The role of iron in erythropoiesis in the absence and presence of erythropoietin therapy.
Goodnough LT
Nephrol Dial Transplant; 2002; 17 Suppl 5():14-8. PubMed ID: 12091601
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of intestinal iron absorption by indirect methods in patients on hemodialysis receiving oral iron and recombinant human erythropoietin.
Deira J; Martín M; Sánchez S; Garrido J; Núñez J; Tabernero JM
Am J Kidney Dis; 2002 Mar; 39(3):594-9. PubMed ID: 11877579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
